NCT03667170View on ClinicalTrials.gov

KN035 for dMMR/MSI-H Advanced Solid Tumors

PHASE2RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

December 30, 2025

Study Completion Date

December 15, 2026

Conditions

Solid Tumor

Interventions

BIOLOGICAL

KN035

subcutaneous injection

Trial Locations (1)

100010

RECRUITING

Peking University Cancer Hospital, Peking University, Beijing

All Listed Sponsors

lead

3D Medicines (Sichuan) Co., Ltd.

INDUSTRY